Definitions
Sorry, no definitions found. Check out and contribute to the discussion of this word!
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word non-responder.
Examples
-
Not sure whether this is OT or not, but in all the back-and-forth on this matter, has anyone in a position to command a response (or at least, to embarrass a non-responder) asked Harvard to list the subjects/positions which are taboo there, on the web?
-
The idea of you as a "non-responder" is laughable.
. . . . Care to Comment? Fresca 2010
-
Not sure whether this is OT or not, but in all the back-and-forth on this matter, has anyone in a position to command a response or at least, to embarrass a non-responder asked Harvard to list the subjects/positions which are taboo there, on the web?
-
Try some "chronic non-responder" analysis to boost response in the later contacts.
Impact of Frequency of Contact in Membership Recruitment Tony Rossell 2009
-
"While we would expect Tysabri to be used predominantly as second-line treatment, the importance of opening up for first-line use would allow physicians flexibility to use Tysabri in more difficult to treat cases earlier on and allow faster penetration into the non-responder market."
Eye On Stocks For Thursday, March 9Eye On Stocks For Thursday, March 9, 2006 2006
-
"While we would expect Tysabri to be used predominantly as second-line treatment, the importance of opening up for first line use would allow physicians flexibility to use Tysabri in more difficult-to-treat cases earlier on and allow faster penetration into the non-responder market," wrote Jennifer Chao of Deutsche Bank, in a report sent to investors on Wednesday afternoon.
-
"Both front-line and non-responder patients represent sizable opportunities that may be addressed with new HCV therapies, and we believe that a new drug class that possesses synergistic activity with other agents has blockbuster potential."
unknown title 2011
-
The likelihood of being a non-responder varies by race, according to the FDA.
chicagotribune.com - 2010
-
Phase 2 trial aims to expand the safety database for NOV-205 and assess its effects on the same efficacy-related endpoints using a comparable dosing regimen, although this trial is being conducted in a more difficult to treat interferon/ribavirin non-responder patient population.
DWS Pill Scribe pillscribe 2010
-
Telaprevir is forecasted to earn 71 percent patient share in the U.S. hepatitis C non-responder market in 2013.
THE MEDICAL NEWS 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.